It has also been previously reported that while prostate cancer patients had a similar frequency of total Tregs in peripheral blood as healthy donors, the CTLA-4+ Tregs from patients had greater suppressive functionality [53]. This evidence concerns the gene CTLA4 and Familial prostate cancer.